1. Pink Sheet
  2. >>R&D

US FDA Eager To INTERACT With Start-Ups, Not Check Boxes

 
• By Michael McCaughan

A US FDA webinar for start-up sponsors showcased staff who sound enthusiastic about helping drug developers advance their projects, while also emphasizing the importance of early and continual engagement with the agency.

meeting
The FDA wants start-ups to take advantage of all meeting opportunities. • Source: Shutterstock

The new INTERACT meeting process can be a critical step for start-up sponsors to avoid early stumbles in their attempts to move into human trials, US Food and Drug Administration officials emphasized during a recent webinar offering “Regulatory Do’s and Don’ts” for small businesses.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Pink Sheet